info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Microneedle Drug Delivery Systems Market Global Report, 2030

Microneedle Drug Delivery Systems Market: By Type (Solid, Hollow, Dissolving, Coated, Others), By Material (Silicon, Metal, Polymer, Others), By Application (Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others), By Geography, Size, Global Report, Forecast, 2021-2030

Published On: Apr-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 12144109

Report DescriptionTable of Contents

Industry Report and Statistics

In 2020, the Global Microneedle Drug Delivery Systems Market share was valued at USD 5.37 billion. The microneedle drug delivery systems market is forecasted to grow up to USD 10.14 billion in 2030, with an estimated CAGR of 6.5%. The North American region dominated the market by accounting for over 40% of the total market share in the world. Microneedles are the devices that are used in the delivery of pre-treatment in pore formation to the skin. These microneedles penetrate the skin to create a passage for drug transportation through the human body.

 

Microneedle Drug Delivery Systems Market Infographic 2020-2030

 

Market Drivers - Rising Prevalence of Obesity, Research and Development Proficiencies, Growing Investment for Healthcare Facilities

  • The rise in the overweight and obese population globally is significant in increasing the microneedle drug delivery systems market's size. According to the WHO, 39% of the world's population was overweight, and 13% of the total population was obese in 2016. 

 

  • The growing investment in better healthcare facilities and improvement of healthcare infrastructure worldwide is a significant driver that can foster the market's growth. In addition, the mounting number of strategic collaborations and partnerships between the public and private players for funding and application of new technologies can help boost the growth of the Microneedle Drug Delivery market extensively.

 

  • Moreover, the products that are currently assisting the market's growth are microneedle patch, hydrogel microneedle, silicon microneedle, metal microneedles, polymer microneedles, ceramic microneedles, oligonucleotide delivery, coated microneedles, dissolving microneedles, and hollow microneedles. Microneedles are currently used for medical applications such as vaccine therapy, peptide delivery, hormone delivery, lidocaine delivery, pain therapy, ocular delivery, and cancer therapy. One current product is CIT-8 (collagen induction therapy). Microneedles can also be expanded into the cosmetics industry, with the C-8 (Cosmetic type) being a prime example.

 

microneedle drug delivery systems market by share 2020-2030

 

Restraints - High Cost Associated with R&D Proficiencies, Limited Infrastructural Facilities

  • The research and development costs of the microneedle drug delivery system are very high, thus threatening the development of newer and improved technologies and, therefore, it is hampering the market's overall growth.

 

  • The limited infrastructural facilities in the companies worldwide can hinder the development of better technologies, which can adversely impact the market growth in future.

 

Opportunities - Upsurge in the Private-public Funding for Targeted Research, Rising Product Innovations and Developments, and Newer Applications

  • Due to the collaboration of public and private sectors for targeted research in developing countries and the presence of highly improved technologies, a tremendous opportunity to improve the overall market's growth in the future can be created.

 

  • The rising costs in the research and development activities for medical instruments and devices, especially in the developed and developing countries, will create better market opportunities in the future. In addition, R&D focused on reducing obesity will also create more significant market opportunities.

 

  • Moreover, the implementation of newer and improved technologies can help the market to grow further in the future. Other than the currently marketed products of transdermal drug delivery system, the use of nanotechnology in drug delivery, microneedles for drug delivery via the gastrointestinal tract, microneedle transdermal drug delivery, transdermal microneedles for drug delivery applications, transdermal microneedles for drug delivery applications, nanoparticle drug delivery, Solid microneedle, Hydrogel microneedle, 3m Microneedle Drug Delivery, Microneedle array, MS-4, MicroHyala, microstructured transdermal systems and microneedle drug delivery systems can augment the growth of the market share further in the upcoming years. 

 

Market Analysis Of Different Segments Covered in the Report

Based on Type

  • Solid

  • Hollow

  • Dissolving

  • Coated

  • Others

 

Based on Material

  • Silicon

  • Metal

  • Polymer

  • Others

 

Based on Application

  • Dermatology

  • Drug Delivery

  • Pain Management

  • Cancer Therapy

  • Vaccine Delivery

  • Others

 

microneedle drug delivery systems market by application 2020-2030

 

Regional Coverage Analysis

North America

  • United States of America

  • Canada

 

Europe

  • United Kingdom

  • Germany

  • France

  • Italy

  • Spain

 

Asia-Pacific

  • China

  • Japan

  • India

  • Thailand

  • South Korea

 

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

 

Middle East and Africa

  • Saudi Arabia

  • South Africa

  • United Arab Emirates

 

Segments Analysis & Insights

Based on Type, the hollow microneedle segment had the largest revenue share of more than 26% in 2020. The hollow microneedles can administer a larger drug dose to a patient, making them suitable for vaccine and hormonal therapy.

 

Based on Material, the metal microneedle segment accounted for the largest revenue share, with more than 27% in 2020. Metals are more preferred for microneedle manufacture as they are strong enough to avoid breaking.

 

Based on application, the vaccine delivery segment is anticipated to expand quickly at a CAGR of 6.3% from 2020 to 2030. Due to the increased awareness of vaccination by the population, scientists can develop new vaccine administration methods.

 

Based on the region, North America accounted for the most significant share of market revenue, with over 40% in 2020. Due to the governments in North America forming different projects and reducing R&D costs, the North American market for microneedles has skyrocketed.

microneedle drug delivery systems market by region 2020-2030

Global Microneedle Drug Delivery Systems Market Competitive Landscape Analysis

Competitors in this market are evaluated based on company financials, revenue generated, market potential, new market investment, investment in R&D, and global presence.

The key players in this market are:

 

Microneedle Drug Delivery Systems Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 5.71 billion

The revenue forecast in 2030

USD 10.08 billion

Growth rate

CAGR of approximately 6.5%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based on Type, Based on Material, Based on Application, Based on Region

Based on Type

Solid, Hollow, Dissolving, Coated, Others

 

Based on Material

Silicon, Metal, Polymer, Others

Based on Application

Dermatology, Drug Delivery, Pain Management, Cancer Therapy, Vaccine Delivery, Others

By Region

North America, Europe, Latin America, Middle East and Africa

Country Scope

United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa

Company Usability Profiles

AdminMed nanoBioSciences LLC, Becton, Dickinson and Company, Zosano Pharma Corporation, Raphas Co. Ltd., Nanopass Technologies Ltd., Corium International, Inc. (Gurnet Point Capital), Valeritas, Inc. (Zealand Pharma), Nitto Denko Corporation, Endoderma Ltd., Innoture Medical Technology Limited

 

Recent Developments

  • In 2022, Zosano Pharma announced a publication of clinical data which demonstrated comparable immunogenicity of a Trivalent Influenza Vaccine formulated on the company's transdermal microneedle system versus an intramuscular injection of the vaccine at a higher dose. In addition, the data revealed that the vaccine was administered through their microneedle system and produced antibody levels that met the EMEA's three guidelines for the efficacy requirements of the influenza vaccine and were efficiently handled by the testers.

  • In 2021, PharmaTher announced positive research results for its LSD microneedle patch. These results can provide support for the company to continue phase 2 clinical studies in 2022 with LSD for various indications.

 

Various Microneedle Drug Delivery Systems Devices that Key Market Leaders Developed:

Name of the Product

Function

Key Players

MicroHyala

Treatment of age spots, acne and anti-ageing cosmetic products

CosMED Pharmaceutical Co. Ltd.

Soluvia

Intradermal Vaccination

Sanofi Pasteur Europe

MF-8 type

Treatment of Scars

Dermaroller

MS-4

Treatment of Acne Scars

Dermaroller

LiteClear

Treatment of acne and skin blemishes

Nanomed Skincare

h-patch

Delivery of drugs in subcutaneous tissue

Valeritas

Microstructured Transdermal System

Delivery of biologics and other small molecules

3M

Frequently Asked Question About This Report

b: The global microneedle drug delivery systems market size was $5.71 billion in 2021 and is predicted to reach $10.08 billion by 2030, with a CAGR of 6.5%.

b: The main factors that contribute to the growth of the market are the rising prevalence of obesity, R&D proficiencies, and the global investment in healthcare facilities.

b: The metallic Material has captured the most market share globally, with more than 27% in 2021.

b: North America has the most revenue in the market, with more than 40%

b: The global microneedle drug delivery systems market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2030 to reach USD $ 10.08 billion by 2030.

.